Pages that link to "Q62660604"
Jump to navigation
Jump to search
The following pages link to Loss of P16 Expression and Chromosome 9p21 LOH in Predicting Outcome of Patients Affected by Superficial Bladder Cancer (Q62660604):
Displaying 15 items.
- Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis (Q26747600) (← links)
- Common genetic variants in the 9p21 region and their associations with multiple tumours (Q28396581) (← links)
- Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC) (Q30433431) (← links)
- DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection (Q33360111) (← links)
- Personalized therapy for urothelial cancer: review of the clinical evidence (Q36062762) (← links)
- Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history (Q36085868) (← links)
- Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium (Q37770780) (← links)
- Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity (Q38297729) (← links)
- The prognostic value of FGFR3 mutational status for disease recurrence and progression depends on allelic losses at 9p22 (Q38618562) (← links)
- Differential impact of RB status on E2F1 reprogramming in human cancer (Q46068832) (← links)
- Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma (Q46343964) (← links)
- Molecular characteristics of urothelial neoplasms in children and young adults: a subset of tumors from young patients harbors chromosomal abnormalities but not FGFR3 or TP53 gene mutations. (Q53239118) (← links)
- [Tumors of the urinary system. Current and old problems]. (Q54699857) (← links)
- CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making (Q58695446) (← links)
- Prognostic value of loss of heterozygosity at chromosome 9p in non-muscle-invasive bladder cancer (Q84530169) (← links)